Clinical trial
Annual Study to Investigate Inactivated Virosomal Influenza Vaccine for the…
NCT00345462 · Solvay Pharmaceuticals, Industry · Withdrawn
Key facts
| NCT number | NCT00345462 |
|---|---|
| Title | Annual Study to Investigate Inactivated Virosomal Influenza Vaccine for the 2006/2007 Influenza Season in Europe. |
| Official title | Immunogenicity and Reactogenicity of Trivalent Virosomal Influenza Vaccine Invivac® for the Season 2006/2007. An Open, Baseline-controlled Study in Two Groups of Healthy Subjects: Adults and Elderly. |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Healthy Volunteers |
| Intervention type | Biological |
| Interventions | Trivalent virosomal influenza vaccine |
| Enrollment | 120 |
| Start date | Jun 1, 2006 |
| First posted | Jun 28, 2006 |
| Last update posted | Feb 8, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: